terrorist or similar activity. Additional factors that could cause actual results to differ are discussed in Part I, Item 1A (Risk Factors) of the Company's report to the SEC on Form 10-K filed with the SEC on February 23, 2009. Forward-looking statements contained in this press release are made only as of the date hereof, and we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Change in Accounting for Convertible Debt Securities
In May 2008, the FASB issued FSP No. APB 14-1 "Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)" ("FSP APB 14-1")." Under this standard, convertible debt securities that may be settled in cash (or other assets), including partial cash settlement, would be separated into a debt and equity component. This change in principle, which is effective for us as of January 1, 2009, was applied retrospectively to previously issued convertible debt instruments. The adoption of this new accounting standard increased our 2008 and 2007 non-cash interest expense by approximately $13 million per year, resulting in a reduction of our diluted earnings per share by approximately $0.12 in 2008 and 2007. The impact for the first quarter 2009 was additional interest expense of $2.1 million, net of income taxes of $1.4 million, or $.03 per fully diluted share.
Non-GAAP Financial Measures
"GAAP" refers to financial information presented in accordance with generally accepted accounting principles in the United States.
To supplement the condensed consolidated financial statements and discussion presented on a GAAP basis, this press release includes non-GAAP financial measures with respect to the quarters ended March 31, 2009 and 2008 and with respect to Outlook for 2009. ManagPage: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Related biology technology :1
. Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes2
. Beckman Coulter to Webcast Annual Stockholders Meeting3
. Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation4
. Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals5
. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share6
. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes7
. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference8
. Beckman Coulter to Host Annual Business Review9
. Beckman Coulter to Present at Upcoming Healthcare Conferences10
. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference11
. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care